by admin | Oct 16, 2018 | Biomanufacturing, Industrial Biotechnology, Policy
What is OpenMTA? OpenMTA is a set of legal frame-work that allows researchers, across academia and industry, to share biological materials with minimal cost and legal red-tape. The agreement, which has been designed by various institutes/companies in the UK (including...
by admin | Aug 13, 2018 | Biomanufacturing, Industrial Biotechnology, Policy
CRISPR/Cas9 (now referred to as CRISPR) , is a new technology used for highly-targeted genome editing using an enzyme (Cas9) called an endonuclease. The endonuclease cuts the DNA where you target it, and was originally found in a species of bacteria. The European High...
by admin | Aug 13, 2018 | Diagnostics, FoodHealth, Industrial Biotechnology, Policy
UoS shortlisted for international biotech prize University of Suffolk Biotechnology research unit have been shortlisted for a prestigious prize. This is the Cultivating Excellence award, by RegMedNet. This is significant as this is an international award...
by admin | Jul 31, 2018 | Biomaterials, FoodHealth, Industrial Biotechnology, Investment, Policy
Giant Glasshouse to use hydroponics for tomatoes in Suffolk Sterling Suffolk Ltd have rapidly constructed their mega-greenhouse structure for rapid growing tomatoes. To grow crops quickly they will use hydroponic growing technology. The mega-greenhouse is the size of...
by admin | Jul 31, 2018 | Policy
Mr Parfrey at Norwich Research Park, Image source: EDP Bethany Whymark Norwich Research Park – 2030 and beyond Norwich Research Park launched its new vision looking ahead to 2030 and beyond. The vision was unveiled by David Parfrey on 20th July....
by admin | Mar 24, 2017 | Brexit, Policy
Biotech in the age of Brexit What could leaving the European Union mean for biotech businesses and our bioeconomy? The UK’s vote to leave the European Union has created major uncertainty for the future of many industry sectors, and biotech is no exception;...
